1. Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. (4th November 2015) Authors: Linch, Stefanie; Kasiewicz, Melissa J; McNamara, Michael; Hilgart, Ian; Farhad, Mohammad; Redmond, William Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biomarkers of survival statistics (boss) analytical platform. (4th November 2015) Authors: McNamara, Michael; Hilgart, Ian; Redmond, William Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomarkers of survival statistics (boss) analytical platform. Issue 2 (December 2015) Authors: McNamara, Michael; Hilgart, Ian; Redmond, William Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Galectin-3 inhibition using novel inhibitor GR-MD-02 improves survival and immune function while reducing tumor vasculature. Issue 2 (December 2015) Authors: Linch, Stefanie; Kasiewicz, Melissa; McNamara, Michael; Hilgart, Ian; Farhad, Mohammad; Redmond, William Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗